News Daily News FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent Michael O'Riordan March 16, 2016
News Daily News FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting Michael O'Riordan March 14, 2016
News Daily News Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR Michael O'Riordan March 14, 2016
News Daily News As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR Michael O'Riordan March 14, 2016
News Daily News El Calcio Coronario Va Más Allá del Riesgo CV para Predecir una Lista de Otras Patologías Shelley Wood March 10, 2016
News Daily News Coronary Calcium Goes Beyond CV Risk to Predict a Spate of Other Diseases Shelley Wood March 10, 2016
News Daily News ¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación? Michael O'Riordan March 09, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Industry News Successful Transapical Access and Closure Clinical Test Performed in 6 Consecutive Invivo Procedures Using the Heartstitch TA March 09, 2016
News Daily News El Controvertido Ensayo LIGHT Ahora Publicado No Arroja Luz sobre los Riesgos CV de Contrave Michael O'Riordan March 08, 2016
News Daily News Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave Michael O'Riordan March 08, 2016
News Daily News Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral Shelley Wood March 07, 2016
News Daily News Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease Michael O'Riordan March 07, 2016
News Daily News Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says Shelley Wood March 07, 2016